Dave Osthus
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Dave Osthus has a total of 553 co-authors. Here are the top co-authors by number of shared publications:
- Sara Y. Del Valle
Los Alamos National Laboratory
12 shared publications - Lauren Ann Castro
Los Alamos National Laboratory
8 shared publications - Nicholas G. Reich
University of Massachusetts Amherst, Amherst, MA, USA
7 shared publications - Kelly Renee Moran
Los Alamos National Laboratory
6 shared publications - Lauren J. Beesley
Information Systems & Modeling, Los Alamos National Laboratory
6 shared publications - Alexander C. Murph
Los Alamos National Laboratory
5 shared publications
Latest Publications
- 7 October 2026
- Published by Taylor & Francis in Journal of the American Statistical Association
- p. 1-24
Statistical methods for partitioning ribbon and globally-distributed flux using data from the Interstellar Boundary Explorer
1 IntroductionThe Interstellar Boundary Explorer (IBEX) satellite is part of an Earth-orbiting U.S. National Aeronautics and Space Administration (NASA) mission to study the boundaries of the bubbl...
- 7 October 2026
- Published by Taylor & Francis in Journal of the American Statistical Association
- p. 1-24
Statistical methods for partitioning ribbon and globally-distributed flux using data from the Interstellar Boundary Explorer
1 IntroductionThe Interstellar Boundary Explorer (IBEX) satellite is part of an Earth-orbiting U.S. National Aeronautics and Space Administration (NASA) mission to study the boundaries of the bubbl...
- Open Access
- 27 August 2026
- Published by Public Library of Science (PLoS) in PLOS Computational Biology
- Vol. 22 (8) , e1014630
Leveraging synthetic and genetic data to improve epidemic forecasting
Forecasting infectious disease outbreaks is hard. Forecasting emerging infectious diseases with limited historical data is even harder. In this paper, we investigate ways to improve emerging infectious disease forecasting when little pathogen-specific training data are available. Specifically, we explore two sources of information that may be available near the start of an emerging disease outbreak: synthetic data and genetic information. For this investigation, we conducted an experiment where we trained deep learning models on different combinations of real and synthetic data, both with and without genetic information, to explore how these models compare when forecasting COVID-19 cases for US states. All models are developed with an eye towards forecasting the next pandemic. We find that models trained with synthetic data have better forecast accuracy than models trained on real data alone, and models that use genetic variants have better forecast accuracy compared to those that do not. All models outperformed a baseline persistence model, a benchmark that proved challenging for many real-time COVID-19 case forecasting models, and multiple models outperformed the COVIDHub-4_week_ensemble. This paper demonstrates the value of these underutilized sources of information and provides a blueprint for forecasting future pandemics.
- 27 August 2026
- Published by Public Library of Science (PLoS) in PLOS Computational Biology
- Vol. 22 (8) , e1014630
Open AccessLeveraging synthetic and genetic data to improve epidemic forecasting
Forecasting infectious disease outbreaks is hard. Forecasting emerging infectious diseases with limited historical data is even harder. In this paper, we investigate ways to improve emerging infectious disease forecasting when little pathogen-specific training data are available. Specifically, we explore two sources of information that may be available near the start of an emerging disease outbreak: synthetic data and genetic information. For this investigation, we conducted an experiment where we trained deep learning models on different combinations of real and synthetic data, both with and without genetic information, to explore how these models compare when forecasting COVID-19 cases for US states. All models are developed with an eye towards forecasting the next pandemic. We find that models trained with synthetic data have better forecast accuracy than models trained on real data alone, and models that use genetic variants have better forecast accuracy compared to those that do not. All models outperformed a baseline persistence model, a benchmark that proved challenging for many real-time COVID-19 case forecasting models, and multiple models outperformed the COVIDHub-4_week_ensemble. This paper demonstrates the value of these underutilized sources of information and provides a blueprint for forecasting future pandemics.
- Open Access
- 1 August 2026
- Published by Office of Scientific and Technical Information (OSTI)
Dst Forecasting Status Summary: What Worked, What Did Not, and Why
- 1 August 2026
- Published by Office of Scientific and Technical Information (OSTI)
Open AccessDst Forecasting Status Summary: What Worked, What Did Not, and Why
- Open Access
- 20 March 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
A disease-agnostic approach to ensemble learning for infectious disease forecasting
Accurate forecasting of infectious diseases drives modern public health interventions that reduce morbidity and mortality. However, accurate forecasting in real-time remains a challenge for the modeling community. Ensembling has emerged as a critical tool for accurate forecasting by leveraging multiple component (individual) models into a single weighted average. Traditional ensembling strategies have relied on bespoke component models that weight the contributions of individual models according to extensive historical data for specific diseases. This is impractical for an emerging disease, since there would be very little – if any – data. We propose an ensembling strategy, called epiFFORMA , that determines component weights for an ensemble model without historical data and is therefore disease-agnostic. The epiFFORMA model builds upon the FFORMA model from the M4 forecasting competition to harness epidemiological dynamics through synthetic data. We demonstrate that epiFFORMA performs better than a naive, equal-weighting ensembling strategy when forecasting outbreaks of COVID-19, diphtheria, influenza-like illness, dengue, measles, mumps, polio, rubella, smallpox, and chikungunya. We further show that epiFFORMA, on average, performs better than the individual component models in the ensemble.
- 20 March 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
Open AccessA disease-agnostic approach to ensemble learning for infectious disease forecasting
Accurate forecasting of infectious diseases drives modern public health interventions that reduce morbidity and mortality. However, accurate forecasting in real-time remains a challenge for the modeling community. Ensembling has emerged as a critical tool for accurate forecasting by leveraging multiple component (individual) models into a single weighted average. Traditional ensembling strategies have relied on bespoke component models that weight the contributions of individual models according to extensive historical data for specific diseases. This is impractical for an emerging disease, since there would be very little – if any – data. We propose an ensembling strategy, called epiFFORMA , that determines component weights for an ensemble model without historical data and is therefore disease-agnostic. The epiFFORMA model builds upon the FFORMA model from the M4 forecasting competition to harness epidemiological dynamics through synthetic data. We demonstrate that epiFFORMA performs better than a naive, equal-weighting ensembling strategy when forecasting outbreaks of COVID-19, diphtheria, influenza-like illness, dengue, measles, mumps, polio, rubella, smallpox, and chikungunya. We further show that epiFFORMA, on average, performs better than the individual component models in the ensemble.
- Open Access
- 10 December 2025
- Published by Springer Nature in BMC Public Health
- Vol. 26 (1)
When to vaccinate for seasonal influenza: check the peak forecast
Seasonal influenza infects 5-20% of people every year in the United States, resulting in hospitalizations, deaths, and adverse economic impacts. To mitigat
- 10 December 2025
- Published by Springer Nature in BMC Public Health
- Vol. 26 (1)
Open AccessWhen to vaccinate for seasonal influenza: check the peak forecast
Seasonal influenza infects 5-20% of people every year in the United States, resulting in hospitalizations, deaths, and adverse economic impacts. To mitigat
- Open Access
- 30 October 2025
- Published by Springer Nature in Journal of Mathematical Biology
- Vol. 91 (6) , 1-24
Mapping Incidence and Prevalence Peak Data for SIR Modeling Applications
Infectious disease modeling and forecasting have played a key role in helping assess and respond to epidemics and pandemics. Recent work has leveraged data on disease peak infection and peak hospital incidence to fit compartmental models for the purpose of forecasting and describing the dynamics of a disease outbreak. Incorporating these data can greatly stabilize a compartmental model fit on early observations, where slight perturbations in the data may lead to model fits that forecast wildly unrealistic peak infection. We introduce a new method for incorporating historic data on the value and time of peak incidence of hospitalization into the fit for a Susceptible-Infectious-Recovered (SIR) model by formulating the relationship between an SIR model’s starting parameters and peak incidence as a system of two equations that can be solved computationally. We demonstrate how to calculate SIR parameter estimates – which describe disease dynamics such as transmission and recovery rates – using this method, and determine that there is a noticeable loss in accuracy whenever prevalence data is misspecified as incidence data. To exhibit the modeling potential, we update the Dirichlet-Beta State Space modeling framework to use hospital incidence data, as this framework was previously formulated to incorporate only data on total infections. This approach is assessed for practicality in terms of accuracy and speed of computation via simulation.
- 30 October 2025
- Published by Springer Nature in Journal of Mathematical Biology
- Vol. 91 (6) , 1-24
Open AccessMapping Incidence and Prevalence Peak Data for SIR Modeling Applications
Infectious disease modeling and forecasting have played a key role in helping assess and respond to epidemics and pandemics. Recent work has leveraged data on disease peak infection and peak hospital incidence to fit compartmental models for the purpose of forecasting and describing the dynamics of a disease outbreak. Incorporating these data can greatly stabilize a compartmental model fit on early observations, where slight perturbations in the data may lead to model fits that forecast wildly unrealistic peak infection. We introduce a new method for incorporating historic data on the value and time of peak incidence of hospitalization into the fit for a Susceptible-Infectious-Recovered (SIR) model by formulating the relationship between an SIR model’s starting parameters and peak incidence as a system of two equations that can be solved computationally. We demonstrate how to calculate SIR parameter estimates – which describe disease dynamics such as transmission and recovery rates – using this method, and determine that there is a noticeable loss in accuracy whenever prevalence data is misspecified as incidence data. To exhibit the modeling potential, we update the Dirichlet-Beta State Space modeling framework to use hospital incidence data, as this framework was previously formulated to incorporate only data on total infections. This approach is assessed for practicality in terms of accuracy and speed of computation via simulation.
- Open Access
- 9 September 2024
- Published by Springer Nature in Research Square
When to vaccinate for seasonal influenza? Check the peak forecast
Background: Seasonal influenza infects 5-20% of people every year in the United States, resulting in hospitalizations, deaths, and adverse economic impacts. To mitigate these impacts, influenza vaccines are developed and distributed annually; however, growing evidence suggests that vaccine effectiveness (VE) wanes over the course of a flu season. Delaying influenza vaccination for older adults has attracted attention as a potential public health strategy. However, given the uncertainties in seasonal peak, vaccine effectiveness, and waning rates, postponing vaccination could also lead to increased morbidity, motivating an evaluation of a range of potential scenarios. Methods: We systematically investigated a broad range of vaccination start times for five age groups under six combinations of initial effectiveness and waning rates, based on influenza cases and vaccine uptake data from 10 influenza seasons. We defined the most favorable vaccination schedule as the one that resulted in the greatest reduction in disease burden. Results: In scenarios with fast waning, all age groups benefit from delaying vaccination regardless of initial VE and peak timing. In scenarios with slower waning, results are mixed. For the 65+ group, high initial VE and slow waning suggests that in early-peaking seasons, early vaccination most effectively reduces disease burden, while in late-peaking seasons delaying vaccination is most effective. For the 65+ group in medium and low initial VE, and slow waning scenarios, delaying vaccination appears to prevent the greatest number of cases, regardless of whether the season peaks early or late. Conclusion: The most favorable vaccination schedule is sensitive to changes in initial VE, waning rate, and peak timing. Given estimates of these quantities from statistical and immunological models and observations, our methods can inform vaccination recommendations in order to most effectively reduce the annual disease burden caused by seasonal influenza. Specifically, accurate peak timing forecasts for the upcoming season have the potential to guide decisions on when to vaccinate.
- 9 September 2024
- Published by Springer Nature in Research Square
Open AccessWhen to vaccinate for seasonal influenza? Check the peak forecast
Background: Seasonal influenza infects 5-20% of people every year in the United States, resulting in hospitalizations, deaths, and adverse economic impacts. To mitigate these impacts, influenza vaccines are developed and distributed annually; however, growing evidence suggests that vaccine effectiveness (VE) wanes over the course of a flu season. Delaying influenza vaccination for older adults has attracted attention as a potential public health strategy. However, given the uncertainties in seasonal peak, vaccine effectiveness, and waning rates, postponing vaccination could also lead to increased morbidity, motivating an evaluation of a range of potential scenarios. Methods: We systematically investigated a broad range of vaccination start times for five age groups under six combinations of initial effectiveness and waning rates, based on influenza cases and vaccine uptake data from 10 influenza seasons. We defined the most favorable vaccination schedule as the one that resulted in the greatest reduction in disease burden. Results: In scenarios with fast waning, all age groups benefit from delaying vaccination regardless of initial VE and peak timing. In scenarios with slower waning, results are mixed. For the 65+ group, high initial VE and slow waning suggests that in early-peaking seasons, early vaccination most effectively reduces disease burden, while in late-peaking seasons delaying vaccination is most effective. For the 65+ group in medium and low initial VE, and slow waning scenarios, delaying vaccination appears to prevent the greatest number of cases, regardless of whether the season peaks early or late. Conclusion: The most favorable vaccination schedule is sensitive to changes in initial VE, waning rate, and peak timing. Given estimates of these quantities from statistical and immunological models and observations, our methods can inform vaccination recommendations in order to most effectively reduce the annual disease burden caused by seasonal influenza. Specifically, accurate peak timing forecasts for the upcoming season have the potential to guide decisions on when to vaccinate.
- Open Access
- 1 July 2024
- Published by American Astronomical Society in The Astrophysical Journal
- Vol. 969 (2) , 166
Statistical Validation of Multiple Related Data Sets—Case Study Using Interstellar Boundary Explorer Satellite Data
Space scientists often face the question of whether data collected by different instruments are measurements of the same source population. This paper proposes a statistical validation method for evaluating the agreement between such related data sets. It offers a detailed case study focused on validating a new data set from the Interstellar Boundary Explorer (IBEX) mission, which serves as a practical how-to guide for similar analyses. Since 2008, the IBEX satellite has been gathering data on heliospheric energetic neutral atoms (ENAs) while being exposed to various sources of background noise, such as cosmic rays and solar energetic particles. The IBEX mission initially released only a qualified triple-coincidence (qABC) data product, which was designed to provide observations of ENAs free of background contamination. Further measurements revealed that the qABC data were in fact susceptible to contamination, having relatively low ENA counts and high background rates. To mitigate this issue, the mission team recently considered releasing a certain qualified double-coincidence (qBC) data product, which has roughly twice the detection rate of the qABC data product. This paper presents a simulation-based validation of the new qBC data product against the already-released qABC data product. The results show that the qBCs can plausibly be said to be measuring the same source population as the qABCs up to an average absolute deviation of 3.6%. Visual diagnostics provide additional confirmation of source rate coherence across data products. The framework introduced here is general and can be applied to other validation problems both within and outside the field of space physics.
- 1 July 2024
- Published by American Astronomical Society in The Astrophysical Journal
- Vol. 969 (2) , 166
Open AccessStatistical Validation of Multiple Related Data Sets—Case Study Using Interstellar Boundary Explorer Satellite Data
Space scientists often face the question of whether data collected by different instruments are measurements of the same source population. This paper proposes a statistical validation method for evaluating the agreement between such related data sets. It offers a detailed case study focused on validating a new data set from the Interstellar Boundary Explorer (IBEX) mission, which serves as a practical how-to guide for similar analyses. Since 2008, the IBEX satellite has been gathering data on heliospheric energetic neutral atoms (ENAs) while being exposed to various sources of background noise, such as cosmic rays and solar energetic particles. The IBEX mission initially released only a qualified triple-coincidence (qABC) data product, which was designed to provide observations of ENAs free of background contamination. Further measurements revealed that the qABC data were in fact susceptible to contamination, having relatively low ENA counts and high background rates. To mitigate this issue, the mission team recently considered releasing a certain qualified double-coincidence (qBC) data product, which has roughly twice the detection rate of the qABC data product. This paper presents a simulation-based validation of the new qBC data product against the already-released qABC data product. The results show that the qBCs can plausibly be said to be measuring the same source population as the qABCs up to an average absolute deviation of 3.6%. Visual diagnostics provide additional confirmation of source rate coherence across data products. The framework introduced here is general and can be applied to other validation problems both within and outside the field of space physics.
- Open Access
- 8 May 2024
- Published by Office of Scientific and Technical Information (OSTI)
Influenza Vaccination Timing
The U.S. Department of Energy's Office of Scientific and Technical Information
- 8 May 2024
- Published by Office of Scientific and Technical Information (OSTI)
Open AccessInfluenza Vaccination Timing
The U.S. Department of Energy's Office of Scientific and Technical Information